Literature DB >> 24922654

Effect of EPH-ephrin signaling on the growth of human leukemia cells.

Yusuke Takahashi1, Mai Itoh1, Nobuo Nara1, Shuji Tohda2.   

Abstract

BACKGROUND: Signaling induced by binding of erythropoietin-producing hepatoma-amplified sequence (EPH) receptors to their cell-surface ephrin ligands is implicated in hematopoiesis and growth of various cancer cells. However, the roles of EPH-ephrin signaling in leukemia have not been elucidated. We investigated the effects of EPHB4 and ephrin B2 on the growth of leukemia cells.
MATERIALS AND METHODS: Seven human leukemia cell lines were used to examine the effects of recombinant ephrin B2 and EPHB4 on cell proliferation by colorimetric WST-1 assay and colony assays; on protein tyrosine phosphorylation; and on mRNA expression by reverse transcription-polymerase chain reaction and microarray analysis.
RESULTS: In an erythroid leukemia-derived cell line AA, exogenous ephrin B2 induced proliferation and colony formation; in addition, it up-regulated protein tyrosine phosphorylation and the expression of growth-related genes such as FBJ murine osteosarcoma viral oncogene homolog B and v-src avian sarcoma viral oncogene homolog.
CONCLUSION: Growth-promoting effects of ephrin B2 were observed in an erythroid leukemia cell line, suggesting that the EPH-ephrin signaling may be involved in the pathology of leukemia. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  EPH receptor; ephrin; leukemia; notch

Mesh:

Substances:

Year:  2014        PMID: 24922654

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT.

Authors:  Akil A Merchant; Aparna Jorapur; Amy McManus; Ren Liu; Valery Krasnoperov; Parvesh Chaudhry; Mohan Singh; Lisa Harton; Mary Agajanian; Miriam Kim; Timothy J Triche; Brian J Druker; Jeffrey W Tyner; Parkash S Gill
Journal:  Blood Adv       Date:  2017-08-28

Review 2.  Ephs and Ephrins in malignant gliomas.

Authors:  Sara Ferluga; Waldemar Debinski
Journal:  Growth Factors       Date:  2014-11-24       Impact factor: 2.511

3.  Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia.

Authors:  Yuhua Li; Huihui Wang; Xiaowen Chen; Huirong Mai; Changgang Li; Feiqiu Wen
Journal:  Oncol Lett       Date:  2017-08-16       Impact factor: 2.967

4.  Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.

Authors:  Parima Udompholkul; Carlo Baggio; Luca Gambini; Yu Sun; Ming Zhao; Robert M Hoffman; Maurizio Pellecchia
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

5.  EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins.

Authors:  Lin Li; Na Xu; Jin-Fang Zhang; Lu-Lu Xu; Xuan Zhou; Bin-Tao Huang; Yu-Ling Li; Xiao-Li Liu
Journal:  Int J Med Sci       Date:  2016-04-28       Impact factor: 3.738

6.  Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.

Authors:  Ahmed F Salem; Si Wang; Sandrine Billet; Jie-Fu Chen; Parima Udompholkul; Luca Gambini; Carlo Baggio; Hsian-Rong Tseng; Edwin M Posadas; Neil A Bhowmick; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2018-02-27       Impact factor: 7.446

7.  Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents.

Authors:  Ahmed F Salem; Luca Gambini; Parima Udompholkul; Carlo Baggio; Maurizio Pellecchia
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-10

8.  The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts.

Authors:  Christin Neuber; Alix Tröster; Reik Löser; Birgit Belter; Harald Schwalbe; Jens Pietzsch
Journal:  Molecules       Date:  2020-11-03       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.